HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of selectin-dependent tumor cell adhesion to endothelial cells and platelets by blocking O-glycosylation of these cells.

Abstract
Expression of sialosyl-Le(x) (SLe(x)) and sialosyl-Le(a) (SLe(a)) on tumor cell lines HL60, Colo205, and U937 was greatly suppressed by application of benzyl-alpha-GalNAc for inhibition of O-linked carbohydrate chain extension, which resulted in reduced adhesion of tumor cells to activated endothelial cells or platelets mediated by ELAM-1 (E-selectin) or GMP-140 (P-selectin). Inhibitors or modifiers of N-glycosylation had no effect on expression of SLe(x) or SLe(a) in these tumor cells. These findings suggest the possibility that targeting of O-glycosylation inhibitors or modifiers to tumor cells may effectively suppress metastatic potential.
AuthorsN Kojima, K Handa, W Newman, S Hakomori
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 182 Issue 3 Pg. 1288-95 (Feb 14 1992) ISSN: 0006-291X [Print] United States
PMID1371678 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Monoclonal
  • Cell Adhesion Molecules
  • E-Selectin
  • Lewis Blood Group Antigens
  • P-Selectin
  • Platelet Membrane Glycoproteins
  • Acetylgalactosamine
Topics
  • Acetylgalactosamine (analogs & derivatives)
  • Antibodies, Monoclonal
  • Blood Platelets (physiology)
  • Cell Adhesion
  • Cell Adhesion Molecules (physiology)
  • Cell Line
  • Cells, Cultured
  • Colonic Neoplasms
  • E-Selectin
  • Endothelium, Vascular (physiology)
  • Flow Cytometry
  • Glycosylation
  • Humans
  • Leukemia, Promyelocytic, Acute
  • Lewis Blood Group Antigens (physiology)
  • Lymphoma, Large B-Cell, Diffuse
  • P-Selectin
  • Platelet Membrane Glycoproteins (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: